BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 28857848)

  • 41. Epidemiology of Ventilator-Associated Pneumonia, microbiological diagnostics and the length of antimicrobial treatment in the Polish Intensive Care Units in the years 2013-2015.
    Wałaszek M; Różańska A; Wałaszek MZ; Wójkowska-Mach J;
    BMC Infect Dis; 2018 Jul; 18(1):308. PubMed ID: 29976151
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of nosocomial postoperative pneumonia in cancer patients: a prospective randomized study.
    Raad I; Hachem R; Hanna H; Abi-Said D; Bivins C; Walsh G; Thornby J; Whimbey E; Huaringa A; Sukumaran A
    Ann Surg Oncol; 2001 Mar; 8(2):179-86. PubMed ID: 11258785
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia.
    Ehrmann S; Barbier F; Demiselle J; Quenot JP; Herbrecht JE; Roux D; Lacherade JC; Landais M; Seguin P; Schnell D; Veinstein A; Gouin P; Lasocki S; Lu Q; Beduneau G; Ferrandiere M; Plantefève G; Dahyot-Fizelier C; Chebib N; Mercier E; Heuzé-Vourc'h N; Respaud R; Gregoire N; Garot D; Nay MA; Meziani F; Andreu P; Clere-Jehl R; Zucman N; Azaïs MA; Saint-Martin M; Gandonnière CS; Benzekri D; Merdji H; Tavernier E;
    N Engl J Med; 2023 Nov; 389(22):2052-2062. PubMed ID: 37888914
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ;
    Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacotherapy for hospital-acquired pneumonia.
    Liapikou A; Rosales-Mayor E; Torres A
    Expert Opin Pharmacother; 2014 Apr; 15(6):775-86. PubMed ID: 24579912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Meropenem monotherapy for the treatment of hospital-acquired pneumonia: results of a multicenter trial.
    Berman SJ; Fogarty CM; Fabian T; Melnick D; Lesky W;
    J Chemother; 2004 Aug; 16(4):362-71. PubMed ID: 15332712
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria.
    Tumbarello M; De Pascale G; Trecarichi EM; De Martino S; Bello G; Maviglia R; Spanu T; Antonelli M
    Chest; 2013 Dec; 144(6):1768-1775. PubMed ID: 23989805
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Efficacy of monotherapy by meropenem in ventilator-associated pneumonia].
    Alvarez Lerma F;
    Antibiot Khimioter; 2001; 46(12):42-52. PubMed ID: 12108093
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and efficacy of colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia as part of a macro-project funded by the Seventh Framework Program of the European Commission studying off-patent antibiotics: study protocol for a randomized controlled trial.
    Rosso-Fernández C; Garnacho-Montero J; Antonelli M; Dimopoulos G; Cisneros JM;
    Trials; 2015 Mar; 16():102. PubMed ID: 25872790
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aerosolized plus intravenous colistin vs intravenous colistin alone for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: A retrospective cohort study.
    Almangour TA; Alruwaili A; Almutairi R; Alrasheed A; Alhifany AA; Eljaaly K; Alkofide H; Alhammad AM; Ghonem L; Alsharidi A
    Int J Infect Dis; 2021 Jul; 108():406-412. PubMed ID: 34111542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extended infusion versus intermittent infusion of imipenem in the treatment of ventilator-associated pneumonia.
    Ibrahim MM; Tammam TF; Ebaed MED; Sarhan HA; Gad GF; Hussein AK
    Drug Des Devel Ther; 2017; 11():2677-2682. PubMed ID: 28919718
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical pulmonary infection score and a spot serum procalcitonin level to guide discontinuation of antibiotics in ventilator-associated pneumonia: a study in a single institution with high prevalence of nonfermentative gram-negative bacilli infection.
    Wongsurakiat P; Tulatamakit S
    Ther Adv Respir Dis; 2018; 12():1753466618760134. PubMed ID: 29506460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Can the clinical pulmonary infection score impact ICU antibiotic days?
    Swoboda SM; Dixon T; Lipsett PA
    Surg Infect (Larchmt); 2006 Aug; 7(4):331-9. PubMed ID: 16978076
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Locally derived versus guideline-based approach to treatment of hospital-acquired pneumonia in the trauma intensive care unit.
    Becher RD; Hoth JJ; Rebo JJ; Kendall JL; Miller PR
    Surg Infect (Larchmt); 2012 Dec; 13(6):352-9. PubMed ID: 23268613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit.
    Palmer LB; Smaldone GC; Chen JJ; Baram D; Duan T; Monteforte M; Varela M; Tempone AK; O'Riordan T; Daroowalla F; Richman P
    Crit Care Med; 2008 Jul; 36(7):2008-13. PubMed ID: 18552684
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early-onset pneumonia after liver transplantation: microbiological findings and therapeutic consequences.
    Weiss E; Dahmani S; Bert F; Janny S; Sommacale D; Dondero F; Francoz C; Belghiti J; Mantz J; Paugam-Burtz C
    Liver Transpl; 2010 Oct; 16(10):1178-85. PubMed ID: 20879016
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study.
    Chastre J; Wunderink R; Prokocimer P; Lee M; Kaniga K; Friedland I
    Crit Care Med; 2008 Apr; 36(4):1089-96. PubMed ID: 18379232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
    Covi M; Velluti G
    J Chemother; 1995 Jun; 7 Suppl 2():137-42. PubMed ID: 8622102
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Michalopoulos A; Kasiakou SK; Mastora Z; Rellos K; Kapaskelis AM; Falagas ME
    Crit Care; 2005 Feb; 9(1):R53-9. PubMed ID: 15693967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emerging trends of nosocomial pneumonia in intensive care unit of a tertiary care public teaching hospital in Western India.
    Bhadade R; Harde M; deSouza R; More A; Bharmal R
    Ann Afr Med; 2017; 16(3):107-113. PubMed ID: 28671150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.